↓ Skip to main content
What is this page? Embed badge

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Overview of attention for article published in Journal of Hematology & Oncology, October 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
345 Dimensions

Readers on

mendeley
74 Mendeley
Summary Patents Dimensions citations
So far, Dimensions has found 345 publications that cite this research output.

345

The most recent citing publications are shown below. View all 345 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.